Institutionen för hälsovetenskaper
Deborah Gustafson is a Professor at the State University of New York-Downstate Medical Center, Department of Neurology, Section for NeuroEpidemiology. She is Adjunct in Sweden at the University of Gothenburg, Sahlgrenska Academy, Neuropsychiatric Epidemiology Research Unit, and at the University Skövde, School of Health and Education. Dr. Gustafson was first to report on a relationship between overweight and obesity and risk of Alzheimer's disease in population-based studies in Sweden. Today, she explores potential mechanisms of adipose tissue, as well as vascular and metabolic factors, in relationship to cognition, neuropsychiatric disorders and brain structure in epidemiologic studies.
In Sweden, she is a co-Investigator on AGECAP, a Swedish initiative. In Brooklyn, she is Co-Principal Investigator on the NIH-funded, Women's Interagency HIV Study (WIHS), a multi-center cohort study in the US, for which she chairs the Aging Working Group and leads efforts in assessments of frailty. She also collaborates with studies in Southwest American Indian communities. Deborah is the recipient of grants from the National Institutes of Health, the European Union, and the Swedish Research Council. Dr. Gustafson has over 130 peer-reviewed or invited publications. She is an invited speaker at international meetings on the topics of adiposity, vascular factors, and prevention of dementia and other mental disorders in the elderly. She is an Associate Editor for Alzheimer's & Dementia, the journal of the US Alzheimer's Association; and a member of the New York Academy of Sciences Nutrition, Dementia and Aging Working Group. Deborah received her educational training from the University of Minnesota (PhD, MS and BA), held an NIH postdoctoral fellowship in Genetic Epidemiology, received docentur in Experimental Psychiatry in Sweden and was awarded the Senior Researcher position in Psychiatric Epidemiology by the Swedish Research Council.
A 10-Year Follow-Up of Adiposity and Dementia in Swedish Adults Aged 70 Years and OlderArnoldussen Ilse A. C., Sundh Valter, Bäckman Kristoffer et al.Journal of Alzheimer's Disease, 2018, 63(4), 1325-1335.
Epidemiology of Type 2 Diabetes and Dementia
Gustafson Deborah R., McFarlane Samy IType 2 Diabetes and Dementia (5-27). Elsevier, 2018.
Relationship between Cognitive and Sleep-wake Variables in Asymptomatic Offspring of Patients with Late-onset Alzheimer's DiseaseAbulafia Carolina, Duarte-Abritta Bárbara, Villarreal Mirta F. et al.Frontiers in Aging Neuroscience, 2017, 9.
Weight Loss in Patients with Dementia: Considering the Potential Impact of Pharmacotherapy
Franx Bart A. A., Arnoldussen Ilse A. C., Kiliaan Amanda J. et al.Drugs & Aging, 2017, 34(6), 425-436.